Aquestive Therapeutics, Inc. AQST Contract with Customer, Liability
Contract with Customer, Liability at other companies
Other financials
Where this comes from
Reported directly by Aquestive Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiability.
The official record: Aquestive Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aquestive Therapeutics, Inc.'s contract with customer, liability.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aquestive Therapeutics, Inc.'s contract with customer, liability?
- Aquestive Therapeutics, Inc. (AQST) reported contract with customer, liability of $20.21M in Q1 2026.
- How has Aquestive Therapeutics, Inc.'s contract with customer, liability changed year-over-year?
- Aquestive Therapeutics, Inc.'s contract with customer, liability decreased by 2.8% year-over-year, from $20.79M to $20.21M.
- What is the long-term trend for Aquestive Therapeutics, Inc.'s contract with customer, liability?
- Over 5 years (2020 to 2025), Aquestive Therapeutics, Inc.'s contract with customer, liability has grown at a 36.5% compound annual growth rate (CAGR), from $4.33M to $20.48M.